Chargement en cours...
Clinical development of novel proteasome inhibitors for cancer treatment
BACKGROUND: Emerging evidence demonstrates that targeting the tumor proteasome is a promising strategy for cancer therapy. OBJECTIVE: This review summarizes recent results from cancer clinical trials using specific proteasome inhibitors or some natural compounds that have proteasome-inhibitory effec...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2009
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3758888/ https://ncbi.nlm.nih.gov/pubmed/19505187 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1517/13543780903002074 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|